Also trades as: 0HF3.L (LSE) · $vol 0M
COR NYSE
Cencora, Inc.
1W: -5.2%
1M: +7.1%
3M: +2.1%
YTD: -3.8%
1Y: -2.0%
3Y: +75.7%
5Y: +178.3%
$325.37
-4.63 (-1.40%)
Weekly Expected Move ±3.1%
$310
$321
$331
$341
$352
Credit Risk of going bust: lower than 74% of companies Debt: 15.7% of company value Bonds: $362.8M held by 313 funds, 60 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $4.32 (down 99%), Cencora, Inc. would be worth roughly what it owes.
Total debt $11.72B against a stock market value of $62.97B.
Distance to default 8.23 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $6.00B (short-term plus half of long-term), stock volatility 32.3%; Altman Z'' 0.42. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $4.32 (down 99%), Cencora, Inc. would be worth roughly what it owes.
Total debt $11.72B against a stock market value of $62.97B.
Distance to default 8.23 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $6.00B (short-term plus half of long-term), stock volatility 32.3%; Altman Z'' 0.42. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.22
Neutral
1 bullish
3 neutral
0 bearish
Articles (7d)
4
Daily Sentiment (7 Days)
Articles (100)
Cencora, Inc. $COR Stock Sold by Axxcess Wealth Management LLC
Notable healthcare headlines for the week: Moderna, Roche, and Abbott Laboratories in focus
Key deals this week: Visa, London Stock Exchange, Tradeweb Markets, Salesforce, and more
Cencora to buy cancer care provider American Oncology Network
IFP Advisors Inc Purchases 14,078 Shares of Cencora, Inc. $COR
Cencora, Inc. $COR Stake Increased by Frank Rimerman Advisors LLC
Cencora, Inc. $COR Stock Position Reduced by Assenagon Asset Management S.A.
23,420 Cencora, Inc. $COR Shares Bought by NorthCrest Asset Manangement LLC
Cencora, Inc. $COR Shares Sold by Bell Asset Management Ltd
Cencora, Inc. $COR Stock Purchased by GAMMA Investing LLC
Cencora, Inc. $COR Stake Lessened by Artemis Investment Management LLP
Park National Corp OH Boosts Holdings in Cencora, Inc. $COR
QRG Capital Management Inc. Buys 18,762 Shares of Cencora, Inc. $COR
Here's Why Cencora (COR) is a Strong Growth Stock
Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?
Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus
Here's Why Cencora (COR) is a Strong Value Stock
Corient Private Wealth LP Purchases 19,068 Shares of Cencora, Inc. $COR
3,733,921 Shares in Cencora, Inc. $COR Purchased by Bank of America Corp DE
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Here's Why Cencora (COR) is a Strong Momentum Stock
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?
Cencora Launches Cell and Gene Therapy Enablement for Health Systems
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen
Is Generics Still a Quiet Profit Engine for Cardinal Health?
Beat the Market the Zacks Way: Accelerant, Insight, General Mills in Focus
Connor Clark & Lunn Investment Management Ltd. Invests $841,000 in Cencora, Inc. $COR
Connor Clark & Lunn Investment Management Ltd. Invests $841,000 in Cencora, Inc. $COR
Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation?
McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate
Advisors Capital Management LLC Takes $748,000 Position in Cencora, Inc. $COR
B. Metzler seel. Sohn & Co. AG Invests $9.62 Million in Cencora, Inc. $COR
"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.
BlackRock Inc. Purchases New Position in Cencora, Inc. $COR
Notable healthcare headlines for the week: Eli Lilly, Hims & Hers Health, and Merck in focus
Cencora (COR) Q3 2026 Earnings Call Transcript
Why Cencora (COR) is a Top Value Stock for the Long-Term
Cardinal Health Earnings: Can Perfection Get Priced In Twice?
Why Cencora (COR) is a Top Momentum Stock for the Long-Term
Here's Why Cencora (COR) is a Strong Growth Stock
Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?
COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Cencora (COR) Surpasses Q3 Earnings Estimates
What's in Store for These 4 Healthcare Companies This Earnings Season?
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?
Can AI-Driven Efficiency and Specialty Demand Boost MCK's Q1 Results?
Solventum to Report Q2 Earnings: What's in Store for the Stock?
GMED's Q2 Earnings on Deck: Will Enabling Technologies Lead Results?
Countdown to Cencora (COR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
McKesson's Compounding Keeps Adding Up
2,060 Shares in Cencora, Inc. $COR Acquired by BankChampaign National Association
Alignment Healthcare (ALHC) Beats Q2 Earnings and Revenue Estimates
Charles River Prepares to Report Q2 Earnings: What's in Store?
Revvity to Report Q2 Earnings: What's in Store for the Stock?
Concentra Group (CON) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Can Pharmacy Wins and Home-Based Care Boost BTSG's Q2 Results?
Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?
Delta Global Management LP Makes New $1.44 Million Investment in Cencora, Inc. $COR
Bank of Nova Scotia Boosts Stock Holdings in Cencora, Inc. $COR
HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical
MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised
Bet on 5 Top-Ranked Stocks With Rising P/E
Wheat futures surge as escalating Russia-Ukraine war threatens Black Sea exports
Notable healthcare headlines for the week: UnitedHealth, Vertex, and CVS Health in focus
Should You Retain CAH Stock After Removal From Several Russell Indices?
Citi's picks and pans for H2 '26: REITs, tech, consumer, health
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
Cencora Launches Enhanced Nucleus Solution for Specialty Practices
Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?
Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know
Amazon Ends Walmart's 13‑Year Hold On The S&P 500 Revenue Crown — But There's A Catch
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
If You Invested $100 In Cencora Stock 10 Years Ago, You Would Have This Much Today
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell?
Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment?
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus
Most healthcare companies report higher Y/Y EPS in strong earnings week
Earnings Scheduled For May 6, 2026
Why Is Cencora Stock Trading Lower On Wednesday?
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
Cencora, Inc. Q2 2026 Earnings Call Summary
Cencora (COR) Q2 2026 Earnings Transcript
COR Stock Falls on Q2 Earnings & Revenue Miss, FY26 EPS View Raised